ConcertAI has announced a new Software-as-a-Service (SaaS) cloud version of TeraRecon’s artificial intelligence (AI)-powered advanced visualisation (AV) and generative AI modules for clinical workflows.
The cloud platform combines Intuition Advanced Visualisation, Eureka Clinical AI, and CARAai into one solution.
The SaaS platform makes TeraRecon’s technology more accessible to healthcare providers.
It enables healthcare organisations to use the latest AI tools in different configurations across enterprise and network levels, ensuring consistent, AI-driven workflows.
TeraRecon’s full suite of solutions is now available in the cloud, removing the need for on-premises infrastructure. Healthcare providers can access AI-powered AV capabilities via a subscription service.
Under the subscription plan, customers also gain access to a library of AI-enabled AV apps and generative AI workflows.
ConcertAI said that this shift supports the increasing adoption of cloud technology in healthcare. Healthcare businesses are using cloud solutions for clinical applications.
ConcertAI CEO Jeff Elton said: “With the broadest multi-modal Data-as-a-Service and leading CARAai AI SaaS solutions, we are supporting thousands of clinicians in their diagnosis and treatment decisions for tens of thousands of patients every day.
“With this combination of cloud and AI SaaS, TeraRecon solutions can assure the productivity of radiological teams globally, timely and accurate diagnoses, and cross-discipline collaboration and care coordination.”
The key advantages of the TeraRecon SaaS include immediate access to the latest AI-powered clinical tools, offering healthcare providers and partners the flexibility to deploy and scale according to various IT environments.
It also ensures automatic software updates and security patches, enhancing compliance without requiring IT intervention.
Additionally, the subscription-based pricing model provides predictable costs, reducing the total cost of ownership and future-proofing against upcoming integrations.
ConcertAI is expanding its TeraRecon portfolio with cloud SaaS capabilities, building on recent innovations like the Intuition 4.10 advanced visualisation software.
Intuition 4.10 is a Food and Drug Administration (FDA)-cleared AI-driven auto-contouring algorithm for cardiac magnetic resonance (MR).
ConcertAI provides predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences.
TeraRecon offers advanced radiological image visualisations and AI-driven decision support for magnetic resonance imaging and CT.
Headquartered in Cambridge, Massachusetts, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo.
In December 2023, the AI solutions provider acquired CancerLinQ to enhance the healthcare learning and research network in oncology.
